Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

Completed

Conditions studied: Pancreas Cancer, Prostate Cancer, Hereditary Cancer, Genetic Predisposition to Disease

In brief

To evaluate an alternative clinical genetics cancer care delivery model, using non-genetic providers to introduce and order genetic testing. 250 prostate and 250 pancreatic patients will be recruiting. They will undergo genetic testing and complete study questionnaires. Results from this pilot study will be used to inform the strategies used by the Clinical Risk Evaluation Program (CREP) Genetic Counelors (CGS) and GI/GU physicians to deliver genetic testing and return genetic risk information to patients with prostate or pancreatic cancer.

Key facts

Study ID
NCT03934606
Run by
Abramson Cancer Center at Penn Medicine
People needed
1488
Starts
2018-01-01
Expected to finish
2025-01-31
Last updated by the study team
2025-04-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.